Back to User profile » Dr Thomas Krieg
Paper published by Dr Thomas Krieg:
Review
Pharmacology and rationale for imatinib in the treatment of scleroderma
Moinzadeh P, Hunzelmann N, Krieg T
Journal of Experimental Pharmacology 2013, 5:15-22
Published Date: 5 April 2013